Cargando…
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
Autores principales: | Ruiz de Garibay, Gorka, Herranz, Carmen, Llorente, Alicia, Boni, Jacopo, Serra-Musach, Jordi, Mateo, Francesca, Aguilar, Helena, Gómez-Baldó, Laia, Petit, Anna, Vidal, August, Climent, Fina, Hernández-Losa, Javier, Cordero, Álex, González-Suárez, Eva, Sánchez-Mut, José Vicente, Esteller, Manel, Llatjós, Roger, Varela, Mar, López, José Ignacio, García, Nadia, Extremera, Ana I., Gumà, Anna, Ortega, Raúl, Plà, María Jesús, Fernández, Adela, Pernas, Sònia, Falo, Catalina, Morilla, Idoia, Campos, Miriam, Gil, Miguel, Román, Antonio, Molina-Molina, María, Ussetti, Piedad, Laporta, Rosalía, Valenzuela, Claudia, Ancochea, Julio, Xaubet, Antoni, Casanova, Álvaro, Pujana, Miguel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231678/ https://www.ncbi.nlm.nih.gov/pubmed/30419005 http://dx.doi.org/10.1371/journal.pone.0207586 |
Ejemplares similares
-
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
por: Ruiz de Garibay, Gorka, et al.
Publicado: (2015) -
Study of breast cancer incidence in patients of lymphangioleiomyomatosis
por: Nuñez, Olivier, et al.
Publicado: (2016) -
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function
por: Farré, Xavier, et al.
Publicado: (2022) -
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
por: Herranz, Carmen, et al.
Publicado: (2021) -
Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
por: Gámez-Baeza, Pablo, et al.
Publicado: (2022)